Robb Gary Charles's Form 4 filing
Corcept Therapeutics Inc (CORT) · filed Sep 15, 2021
- Accession no.
- 0000899243-21-036139
- Filed
- Sep 15, 2021
- Trade date
- Sep 13-15, 2021
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 3 non-derivative transactions. Open-market sales total $1.13M. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Robb Gary CharlesCIK 0001529655 | Officer (Chief Business Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 13, 2021 | Common Stock | SSaleDisposed | −6,341 | $20.89F1 | −$132,463.49 | 136,507 | Direct | |
| Sep 14, 2021 | Common Stock | SSaleDisposed | −806 | $20.76F2 | −$16,732.56 | 135,701 | Direct | |
| Sep 15, 2021 | Common Stock | SSaleDisposed | −47,853 | $20.49F3 | −$980,507.97 | 87,848 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F1
Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range from $20.88 to $20.905. Information on the exact number of shares sold at each sale price can be obtained from the issuer upon request.
Referenced by the price of 1 transaction in Table I.
- F2
Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range from $20.76 to $20.88. Information on the exact number of shares sold at each sale price can be obtained from the issuer upon request.
Referenced by the price of 1 transaction in Table I.
- F3
Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range from $20.405 to $20.58. Information on the exact number of shares sold at each sale price can be obtained from the issuer upon request.
Referenced by the price of 1 transaction in Table I.